The 5 things outside Europe you need to know this week (Samsung $1Bn Biotech IPO, Microbiome blindness, Google Biotech)

27/08/2015 - 2 minutes

Hi there! Here are the 5 most important Biotech things that happened outside Europe in the last few days. 

Enjoy and share!

Samsung, Biogen lining up a $1B IPO for biosimilar joint venture: WSJ

samsung_bioepsis_biogen

Samsung is also interested in Biotech and more precisely in Biosimilars. It created a joint-venture with Biogen and now wants to make a $1B IPO with it.

READ MORE ON FIERCE BIOTECH…

New Research Is a Case of the Gut Leading the Blind

Discoveries in the microbiome field are more and more interesting. Researchers from the NIH even discovered that a form of blindness was caused by gut inflammation due to bacterial infections.

READ MORE ON GENENGNEWS.COM…

Google is doubling down on biotech

google_lens

After announcing Google will now be organized in a holding called Alphabet, co-founder Sergey Brin just announced the creation of a new life science business. It will be run in addition to Calico and will integrate the famous glucose-measuring contact lens as well as many other projects the company has developed inside Google X.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member